About ABS
Overview
ABS is a trading name of ABS Fintech Limited, a forex broker registered in New Zealand since July 2019. It operates the website abs-fx.com, offering leveraged forex and CFD trading to retail clients. The broker claims to provide access to global markets through the MetaTrader 4 platform, though independent assessments have raised concerns about the authenticity of this offering.
The broker positions itself as a legitimate entity with international reach, but its relatively recent establishment and limited public track record make it a largely opaque operation. Traders should approach with caution due to the scarcity of verified information.
Regulation and Licensing
ABS lists regulation by two authorities: the Financial Conduct Authority (FCA) in the United Kingdom and the Financial Service Providers Register (FSPR) in New Zealand. However, regulatory records indicate that the status of these licences is unclear; the FCA entry shows a blank status, and the FSPR record may not be current or active. This lack of confirmed regulatory oversight is a significant red flag.
In practice, the broker may be operating without effective supervision, leaving clients with little recourse in case of disputes. The discrepancy between the broker's claims and the official registers underscores the importance of independent verification.
Trading Platforms and Tools
ABS promotes the MetaTrader 4 (MT4) platform as its primary trading interface. According to industry reports, the version offered may be a counterfeit or unauthorized clone, lacking the security and reliability of the genuine platform. This raises serious concerns about the integrity of trades and data protection.
The broker does not appear to offer alternative platforms like cTrader or proprietary solutions, limiting traders to a single, potentially compromised option. No mobile or web-based variants of MT4 are specifically advertised.
Account Types and Trading Conditions
Public information about account types at ABS is minimal. The broker does not clearly detail its account tiers, minimum deposits, spreads, or leverage on its website. This lack of transparency makes it impossible for traders to evaluate the cost of trading or the suitability of the offering.
Without disclosure of key trading parameters, clients enter the relationship with little understanding of the risks and costs involved. This opacity is typical of brokers with questionable intentions.
Instruments and Markets
ABS claims to provide access to forex trading, but the range of currency pairs or other CFD instruments (indices, commodities, cryptocurrencies) is not specified. The broker’s website does not list available instruments, suggesting a limited or undefined product range.
The absence of a clear instrument portfolio makes it difficult for traders to assess whether the broker meets their diversification needs. It also indicates a lack of operational maturity.
Deposits and Withdrawals
No information is publicly available regarding payment methods accepted by ABS. Common methods such as bank transfers, credit cards, or e-wallets are not mentioned on the website. Similarly, withdrawal policies, processing times, and any associated fees are undisclosed.
This secrecy around financial transactions is a major concern, as it prevents clients from planning their cash flow and understanding potential barriers to accessing their funds. In many scam cases, withdrawal restrictions become evident only after deposits are made.
Conclusion
ABS is a lightly regulated offshore broker with concerning gaps in transparency and verified credibility. Its claimed regulation remains unconfirmed, its trading platform is flagged as counterfeit, and its operational details are largely concealed. Traders should treat this broker with extreme skepticism and consider only fully regulated and transparent alternatives.
Given the severity of the risks identified, FXCanary advises against any engagement with ABS until it provides verifiable proof of its regulatory status and platform authenticity.
Overview compiled by FXCanary from regulatory records and public data. full ABS review